Navigation Links
GeoVax Labs, Inc. Comments on Discontinuance of Merck's HIV Vaccine Trial
Date:9/24/2007

e effective as therapeutics [AIDS treatments]. Studies evaluating these vaccines in already HIV/AIDS infected individuals are being planned.

GeoVax DNA and Recombinant MVA HIV/AIDS vaccines:

-- Use DNA for priming vaccine responses and recombinant MVA to boost

vaccine responses (DNA/MVA vaccine)

-- Protected 22 of 23 (96%) non-human primates for over 3 1/2 years post-

infection with an AIDS causing virus. Five of six non-vaccinated

controls died of AIDS within the 1st year of infection. These trials

used a prototype SIV/HIV vaccine for the HIV vaccine that is being

advanced in human trials

-- Are manufactured & tested under GMP/GLP - EMEA (EU) and FDA guidelines

-- Satisfactorily completed earlier DNA HIV/AIDS vaccine Phase 1 human

trial

-- Are currently being tested in 4 Human Trials. Two started in 2006, two

in mid-07.

-- Have been safe in all tested humans

-- Are demonstrating positive immune responses in the majority of vaccine

recipients

-- Are in planning stage for a larger Phase 2 human trial in 2008

For further information, contact Don Hildebrand or Jennifer Nelms at (404) 727-0971 or visit http://www.geovax.com.

Safe Harbor Statement: All statements in this news release, not statements of historical fact, are forward-looking statements. These statements are based on expectations and assumptions as of the date of this press release and are subject to numerous risks and uncertainties which could cause actual results to differ materially from those described in the forward-looking statements. Risks and uncertainties include, but are not limited to, whether: GeoVax can develop and manufacture these vaccines with the desired characteristics in a timely manner, GeoVax's vaccines will be determined to be safe for use in humans, GeoVax's vaccines will be effective in preventing AI
'/>"/>

SOURCE GeoVax Labs, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. BioSante Pharmaceuticals Announces New Findings for Potential Bird Flu Vaccine
2. DOR BioPharma Announces Issuance of European Patent for Its Oral Multivalent Botulinum Toxin Vaccine BT-VACC
3. From Clinical Cancer Research: Rethinking Therapeutic Cancer Vaccine Trials
4. DOR BioPharma Announces Publication Describing Results of Its Multivalent Botulinum Toxin Vaccine BT-VACC
5. Vaccine Can Prevent Cervical Cancer and Precancerous Lesions
6. Largest Cervical Cancer Vaccine Efficacy Trial Shows Cervarix Provides Excellent Protection Against Lesions Caused by Most Common Cancer-Causing Virus Types
7. Based on Up to 6 Years of Follow-Up, Biovest Announces Favorable Interim Blinded Data for Fast-Tracked Pivotal Phase 3 Clinical Trial of BiovaxID Anti-Cancer Vaccine for Non-Hodgkins Lymphoma
8. HepaLifes PBS-1 Cells for Influenza Vaccine Production Prove Superior at International Conference
9. New Flu Vaccine from PepTcell Could Provide Immunity Against All Strains of Influenza Virus
10. Hypertension Vaccine CYT006-AngQb Achieves Strong Blood Pressure Reduction During Important Early Morning Period When Most Adverse Cardiovascular Events Occur
11. New Flu Vaccine From PepTcell Could Provide Immunity Against All Strains of Influenza Virus
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/22/2014)... 22, 2014 NxStage Medical, Inc. (NASDAQ: ... dialysis products, announced today that the U.S. Food ... One™ to perform hemodialysis overnight while the patient ... hemodialysis. NxStage,s® System One is the first and ... this indication. Home nocturnal hemodialysis ...
(Date:12/22/2014)... Dec. 22, 2014 Research and Markets ... of the "Investment Analysis of the US ... offering. http://photos.prnewswire.com/prnh/20130307/600769 ... US medical device sector identifies the key trends ... capital investments, and mergers and acquisitions. ...
(Date:12/22/2014)... , Dec. 22, 2014 /PRNewswire/ -- RXi Pharmaceuticals Corporation ... focused on discovering, developing and commercializing innovative therapies ... today issued the following open letter to shareholders ... Dr. Med. Sc. Dear RXi Shareholders, ... number of inaccurate statements posted on certain social ...
Breaking Medicine Technology:NxStage Receives FDA Clearance for Home Nocturnal Hemodialysis 2NxStage Receives FDA Clearance for Home Nocturnal Hemodialysis 3Investment Analysis of the US Medical Device Sector 2RXi Pharmaceuticals Issues Open Letter to Shareholders 2RXi Pharmaceuticals Issues Open Letter to Shareholders 3RXi Pharmaceuticals Issues Open Letter to Shareholders 4RXi Pharmaceuticals Issues Open Letter to Shareholders 5RXi Pharmaceuticals Issues Open Letter to Shareholders 6
(Date:12/22/2014)... (PRWEB) December 22, 2014 Physicians in ... (rituximab) for the treatment of non-Hodgkin’s lymphoma (NHL), according ... a leading global healthcare consulting firm. MabThera is the ... (DLBCL), the most common form of NHL. , According ... and Barriers,” the incidence of NHL in China has ...
(Date:12/22/2014)... 22, 2014 Give a loved one ... gift of health and vitality. , For a limited ... top-selling anti-aging formulas in special Holiday Wellness gift packages ... , Each bottle contains cutting-edge, proven nutritional support ... work as well as we age. , ...
(Date:12/22/2014)... Austin, Texas (PRWEB) December 22, 2014 ... hustle and bustle of Black Friday shopping and opted ... publishing and marketing education company, for their 5th annual ... Marketer charged just $7 to attend the 5 ... sales that they promptly donated to support two Central ...
(Date:12/22/2014)... 2014 NAPW honors ... of the Year. She is recognized with this prestigious ... recognized networking organization of professional women in the country, ... of Professional Women is a vibrant networking community with ... Ms. Kreider is passionate and committed to best practices ...
(Date:12/21/2014)... December 22, 2014 In this ... segmented by power source, product, and application. The ... battery-powered, and pneumatic instruments. By product, the market ... accessories segments. The handpieces market is further subdivided ... suction coagulators, laparoscopic instruments, shavers, wire/pin drivers, and ...
Breaking Medicine News(10 mins):Health News:Physicians in China See Most Significant Demand for MabThera Biosimilar 2Health News:Physicians in China See Most Significant Demand for MabThera Biosimilar 3Health News:You Still Have Time to Give the Gift of Health and Vitality to a Mature Loved One 2Health News:Austin Company Digital Marketer Raises 100K to Fight Childhood Cancer 2Health News:Austin Company Digital Marketer Raises 100K to Fight Childhood Cancer 3Health News:National Association of Professional Women Announces Cheryl A. Kreider, President / CEO of Kreider Health Solutions, LLC, a 2014 Professional Woman of the Year 2Health News:Global Powered Surgical Instruments Market Hit to $2.1 billion by 2019 - New Research Report by MarketsandMarkets 2Health News:Global Powered Surgical Instruments Market Hit to $2.1 billion by 2019 - New Research Report by MarketsandMarkets 3Health News:Global Powered Surgical Instruments Market Hit to $2.1 billion by 2019 - New Research Report by MarketsandMarkets 4
... Oklahoma Health Sciences Center has proven that a new drug ... in the prevention of blood clots following hip replacement surgery. ... the formation of blood clots in the deep veins of ... (DVT). The blood clots become life-threatening pulmonary embolisms (PE) when ...
... joined the Greening the Operating Room (GOR) Initiative, Practice ... and prescriptive path to green the country,s operating rooms. ... awareness of the huge contribution made by operating rooms ... 30 percent of a hospital,s total waste. Dartmouth-Hitchcock ...
... and Brigham and Women,s Hospital have shown that they can ... in a form that has been encapsulated in a nanoparticle ... reaches its target. Using the new particles, the researchers ... one-third the amount of conventional cisplatin needed to achieve the ...
... , TUESDAY, Jan. 11 (HealthDay News) -- After a ... "special," today,s young people crave these boosts to their ... research suggests. The self-esteem movement of recent decades ... and praise in a world that won,t necessarily cooperate ...
... as to whether interstitial brachytherapy has advantages compared to other ... newer studies provide proof in this respect. This is the ... and Efficiency in Health Care (IQWiG) on 11 January 2011. ... findings of research already completed in 2007. However, it was ...
... in Spanish . , The work carried out ... an electronic architecture for gamma ray detectors to industry transfer ... through experimental studies at the Gregorio Maran Hospital. The ... and Manuel Desco, from the Department of de Bioengineering and ...
Cached Medicine News:Health News:International research team reports major findings in prevention and treatment of blood clots 2Health News:Dartmouth-Hitchcock joins effort to green nation's operating rooms 2Health News:Delivering a potent cancer drug with nanoparticles can lessen side effects 2Health News:Delivering a potent cancer drug with nanoparticles can lessen side effects 3Health News:For College Students, Praise May Trump Sex and Money 2Health News:For College Students, Praise May Trump Sex and Money 3Health News:Benefit of brachytherapy in patients with early-stage prostate cancer is still unclear 2Health News:Benefit of brachytherapy in patients with early-stage prostate cancer is still unclear 3Health News:Benefit of brachytherapy in patients with early-stage prostate cancer is still unclear 4Health News:New molecular imaging technologies for detecting cellular processes 2
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
Medicine Products: